Endocare and Galil Medical Sign Definitive Merger Agreement
ArKal Medical, Inc. Secures $17.5 Milllion in Series B Financing
Zogenix Announces Clinical Study Results for Sumatriptan DosePro™, a Novel Migraine Treatment
© 2003 Thomas McNerney & Partners - All Rights Reserved.
